The estimated Net Worth of John F Kennedy is at least $314 Tausend dollars as of 26 August 2016. Mr. Kennedy owns over 16,182 units of Harvard Bioscience stock worth over $165,289 and over the last 20 years he sold HBIO stock worth over $0. In addition, he makes $149,184 as Independent Director at Harvard Bioscience.
John has made over 4 trades of the Harvard Bioscience stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 16,182 units of HBIO stock worth $15,049 on 26 August 2016.
The largest trade he's ever made was exercising 118,575 units of Harvard Bioscience stock on 20 May 2014 worth over $328,453. On average, John trades about 3,581 units every 21 days since 2004. As of 26 August 2016 he still owns at least 58,406 units of Harvard Bioscience stock.
You can see the complete history of Mr. Kennedy stock trades at the bottom of the page.
John F. Kennedy serves as Independent Director of the Company. Mr. Kennedy served as President and Chief Financial Officer of Nova Ventures Corporation, the management company providing executive management services to the operating companies of Nova Holdings LLC, Nova Analytics Corporation and Nova Technologies Corporation. From July 2002 to June 2006, Mr. Kennedy served as the President and Chief Financial Officer of Nova Analytics Corporation, a worldwide supplier and integrator of analytical instruments. From August 1999 to April 2002, Mr. Kennedy served as the Senior Vice President, Finance, Chief Financial Officer and Treasurer of RSA Security Inc., an e-business security company. Prior to joining RSA Security, Mr. Kennedy was Chief Financial Officer of Decalog, NV, a developer of enterprise investment management software, from 1998 to 1999. From 1993 to 1998, Mr. Kennedy served as Vice President of Finance, Chief Financial Officer and Treasurer of Natural MicroSystems Corporation, a telecommunications company. Mr. Kennedy, a former CPA, also practiced as a public accountant at KPMG for 6 years. Mr. Kennedy holds an M.S.B.A. in accounting from the University of Massachusetts Amherst.
As the Independent Director of Harvard Bioscience, the total compensation of John Kennedy at Harvard Bioscience is $149,184. There are 6 executives at Harvard Bioscience getting paid more, with James Green having the highest compensation of $2,422,600.
John Kennedy is 71, he's been the Independent Director of Harvard Bioscience since 2000. There are no older and 11 younger executives at Harvard Bioscience.
John's mailing address filed with the SEC is C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL RD., HOLLISTON, MA, 01746.
Over the last 21 years, insiders at Harvard Bioscience have traded over $10,145,146 worth of Harvard Bioscience stock and bought 754,658 units worth $2,380,232 . The most active insiders traders include Earl R Lewis, Bertrand Loy und David Green. On average, Harvard Bioscience executives and independent directors trade stock every 43 days with the average trade being worth of $182,054. The most recent stock trade was executed by James W Green on 13 June 2024, trading 10,000 units of HBIO stock currently worth $29,100.
harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.
Harvard Bioscience executives and other stock owners filed with the SEC include: